Tobam Bausch Health Companies Inc. Transaction History

Tobam

$638 Million
Q2 2024

A detailed history of Tobam transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Tobam holds 26,148 shares of BHC stock, worth $213,106. This represents 0.04% of its overall portfolio holdings.

Number of Shares

26,148

Previous 26,148 -0.0%

Holding current value

$213,106

Previous $249,000 -0.0%

% of portfolio

0.04%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$6.1 - $10.41 $52,374 - $89,380	8,586 Added 48.89%	26,148 $249,000
Q1 2024 May 02, 2024	SELL	$7.77 - $10.61 $36,153 - $49,368	-4,653 Reduced 20.95%	17,562 $186,000
Q4 2023 Jan 26, 2024	SELL	$6.53 - $8.23 $1.47 Million - $1.86 Million	-225,735 Reduced 91.04%	22,215 $179,000
Q3 2023 Oct 31, 2023	SELL	$7.69 - $9.71 $144,671 - $182,674	-18,813 Reduced 7.05%	247,950 $2.05 Million
Q2 2023 Jul 31, 2023	SELL	$5.72 - $8.8 $238,655 - $367,162	-41,723 Reduced 13.53%	266,763 $2.14 Million
Q1 2023 May 03, 2023	BUY	$6.28 - $9.85 $1.94 Million - $3.04 Million	308,486 New	308,486 $2.49 Million
Q3 2022 Nov 02, 2022	BUY	$4.58 - $9.21 $1.46 Million - $2.93 Million	317,908 Added 1685.08%	336,774 $2.34 Million
Q2 2022 Aug 02, 2022	BUY	$7.06 - $23.63 $133,193 - $445,803	18,866 New	18,866 $157,000
Q3 2019 Nov 12, 2019	SELL	$20.88 - $25.66 $187,126 - $229,964	-8,962 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $183,900 - $237,044	8,962 New	8,962 $227,000
Q4 2018 Feb 11, 2019	SELL	$17.64 - $28.32 $4 Million - $6.43 Million	-227,018 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$20.64 - $25.67 $7.63 Million - $9.5 Million	-369,900 Reduced 61.97%	227,018 $5.83 Million
Q2 2018 Aug 03, 2018	BUY	$15.07 - $26.86 $9 Million - $16 Million	596,918 New	596,918 $13.9 Million

Others Institutions Holding BHC

# of Institutions

275

Shares Held

279M

Call Options Held

5.68M

Put Options Held

17.4M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.95B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account